Description
Buy 4-HO-MiPT Online | Secured Tracked Logistics EU
Order High-Purity 4-HO-MiPT for Laboratory Research
Looking to secure a reliable supply of 4-HO-MiPT to buy 4-HO-MiPT online for forensic profiling, mass spectrometry calibration, or neuroreceptor transport assays? As a leading European chemical distributor, we deliver certified, premium-grade 4-HO-MiPT Fumarate Crystal synthesized under strict laboratory quality control parameters. When you buy 4-HO-MiPT online through our encrypted portal, you receive a highly stable analytical reference standard optimized for in vitro testing.
We cater exclusively to corporate entities, academic institutions, and contract research organizations (CROs). Whether your project requires you to buy 4-HO-MiPT online for retail milligram quantities or a long-term bulk 4-HO-MiPT supplier contract, our logistics network ensures consistent purity across every batch.
Technical Specifications & Product Identification Data
-
- Systematic IUPAC Nomenclature: 3-[2-[methyl(propan-2-yl)amino]ethyl]-1H-indol-4-ol (fumarate salt form)
- Standard CAS Registry Number: 77872-43-6 (Base) | 1565150-13-3 (Fumarate Salt Variant)
- Molecular Formula: C₁₄H₂₀N₂O · ½C₄H₆O₄ (Refined Fumarate Crystal Form)
- Exact Molar Mass: 232.32 g/mol (Base) | 290.36 g/mol (Refined Fumarate variant)
- Physical Presentation: Highly stable fine off-white to beige crystal fragments or dense powder matrices
- Structural Classification: Tryptamine derivative and structural analogue of psilocin (4-HO-DMT), featuring an asymmetric substitution pattern with one methyl group and one isopropyl chain bound at the amine nitrogen terminal.
Theoretical Pharmacology & Documented Adverse Effects
Before you buy 4-HO-MiPT online, note that in vitro receptor binding assays classify it as a potent serotonergic agent. Mechanistically, it functions primarily as a high-affinity 5-HT₂A serotonin receptor full agonist, mimicking the structural signaling pathways of traditional indole alkaloids.
Exposure triggers deep neurological and peripheral alterations. Documented systemic effects include mild tachycardia, transient shifts in arterial blood pressure metrics, pupil dilation (mydriasis), hyperthermia, and motor relaxation. Forensic data indicates a heavy risk of drug-induced cognitive dissociation, severe sensory distortions, and extreme psychological overstimulation if standard closed-system laboratory containment protocols fail.
Legal Status & European Regulations
The international legal framework surrounding hydroxylated tryptamine structures is zero-tolerance and heavily monitored:
-
- European Union: Strictly scheduled, banned, or monitored by the European Union Drugs Agency (EUDA) across all EU Member States. National drug schedules—such as Germany’s Betäubungsmittelgesetz (BtMG), the Opiumgesetz in the Netherlands, and equivalent generic legislation in France and Scandinavia—restrict distribution solely to state-authorized scientific installations holding specialized ministerial purchase permits .
- United Kingdom: Strictly criminalized as a Class A controlled substance under the Misuse of Drugs Act 1971 due to broad, sweeping tryptamine analogue framework updates.
- Shipping Policy: Orders addressed to private residential zip codes or unauthorized territories will be delivered securely and discretely at your risk and responsibility.
Authorized Research Use & Safety Warning
The compound 4-HO-MiPT is a synthetic substance classified strictly as an analytical reagent or laboratory reference standard. It is not intended for human or veterinary consumption. Ingestion or accidental exposure poses severe, life-threatening health risks and is illegal under various international and national drug control frameworks. By placing this item into your cart, please ensure that you check the legality status of any product you purchase on our website as we cannot be held responsible for it.
Frequently Asked Questions (FAQ)
What are the primary health risks associated with 4-HO-MiPT?
As an ultra-potent synthetic tryptamine derivative, exposure to 4-HO-MiPT carries high neurological and psychological risks. Documented symptoms following accidental exposure include profound cognitive confusion, sensory overload, metabolic fluctuations driven by hyperthermia, and acute psychological distress if proper handling containment breaks down.
How does 4-HO-MiPT differ structurally from psilocin (4-HO-DMT)?
The core structure of 4-HO-MiPT differs from psilocin entirely at its terminal nitrogen site. While psilocin features an identical hydroxyl group at the 4th position of the indole ring but carries two symmetric methyl groups (-CH₃) on its amine terminal, 4-HO-MiPT features an asymmetric configuration replacing one methyl group with a bulkier isopropyl chain (-CH(CH₃)₂). This structural change noticeability modifies its lipophilicity and resistance to metabolic breakdown.
Can this material be used for consumer testing?
No. This compound is synthesized and handled strictly as an analytical reference standard. It is not approved for human or veterinary consumption, and any such application is completely illegal and carries life-threatening health and legal consequences.
